Standout Papers

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephr... 2001 2026 2009 2017 4.2k
  1. Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes (2001)
    Edmund J. Lewis, Lawrence G. Hunsicker et al. New England Journal of Medicine

Immediate Impact

3 by Nobel laureates 1 from Science/Nature 112 standout
Sub-graph 1 of 11

Citing Papers

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
2024 Standout
Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection
2023 Standout
78 intermediate papers

Works of Richard Rohde being referenced

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
2001 Standout
A controlled clinical trial of angiotensin-converting enzyme inhibition in type I diabetic nephropathy
1992
and 3 more

Author Peers

Author Last Decade Papers Cites
Richard Rohde 1936 2810 459 2139 8 4.6k
Richard D. Rohde 2695 2764 563 2029 16 5.4k
Steen Andersen 2293 3716 482 2891 55 5.9k
Marc A. Pohl 2703 3209 1355 2361 31 6.4k
Leanne Dyal 507 1867 376 1262 24 3.1k
Ole Lederballe‐Pedersen 840 5274 447 2663 23 6.6k
C. E. Mogensen 1224 1366 278 1094 17 2.5k
Aimun Ahmed 2382 3504 1064 1300 19 7.0k
Christina Nowack 735 1736 1116 3106 25 4.2k
Stuart Warren 671 1393 419 3245 22 5.4k
U. Smidt 1156 1355 224 1248 38 2.6k

All Works

Loading papers...

Rankless by CCL
2026